MedTrace Logo

Group A Pharyngitis in Children: The GASPARD Study

NCT03264911 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 360

Last updated 2017-08-29

No results posted yet for this study

Summary

Evaluate the necessity to treat with antibiotics GAS pharyngitis in children in Switzerland. The null hypothesis is that antibiotic treatment is not necessary for GAS pharyngitis in this population.

Conditions

  • Group A Streptococcal Pharyngitis

Interventions

DRUG

Amoxicillin or Placebo

Children will be randomized to either 6 days of amoxicilline or 6 days of placebo treatment

Sponsors & Collaborators

  • Gertrude Von Meissner Foundation

    collaborator OTHER

  • Recherche et Développement des HUG

    collaborator UNKNOWN

  • Société académique de Genève

    collaborator UNKNOWN

  • Klara Posfay-Barbe

    lead OTHER

Principal Investigators

  • Klara Posfay-Barbe · Coordinator

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
3 Years
Max Age
15 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-27
Primary Completion
2018-12-31
Completion
2018-12-31

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03264911 on ClinicalTrials.gov